Article Figures & Tables
Figures
Figure 1: Selection of randomized placebo-controlled trials for systematic review of effectiveness of paroxetine in the treatment of major depression in adults.
Figure 2: Random effects meta-analysis of the effect of paroxetine versus placebo on the proportion of patients who discontinued treatment for any reason. n = number of patients leaving the study for any reason, N = total number of patients, RR = relative risk, CI = confidence interval. Study designations are defined in online Appendix 2 (www.cmaj.ca/cgi/content/full/178/3/296/DC2).
Figure 3: Random effects meta-analysis of the effect of paroxetine versus placebo on the proportion of patients who showed less than 50% improvement in measures of depression. n = number of patients who did not experience an improvement of at least 50% on depression measure, N = total number of patients, RR = relative risk, CI = confidence interval. Study designations are defined in online Appendix 2 (www.cmaj.ca/cgi/content/full/178/3/296/DC2).
Figure 4: Random effects meta-analysis of the effect of paroxetine versus placebo on standardized depression outcomes. SD = standard deviation, SMD = standardized mean difference, CI = confidence interval. Study designations are defined in online Appendix 2 (www.cmaj.ca/cgi/content/full/178/3/296/DC2).
Figure 5: Random effects meta-analysis of the effect of paroxetine versus placebo on the proportion of patients who reported any adverse effects. n = number of patients who reported any adverse effect, N = total number of patients, RR = relative risk, CI = confidence interval. Study designations are defined in online Appendix 2 (www.cmaj.ca/cgi/content/full/178/3/296/DC2).
Figure 6: Random effects meta-analysis of the effect of paroxetine versus placebo on the proportion of patients who reported suicidal tendencies (as indicated by the coding system of the US Food and Drug Administration19). n = number of patients who reported suicidal tendencies, N = total number of patients, RR = relative risk, CI = confidence interval. Study designations are defined in online Appendix 2 (www.cmaj.ca/cgi/content/full/178/3/296/DC2).